文献速递腹部CT

胰腺纤维化评估及其与胰腺癌的关联:与细胞外容积分数的比较

Pancreatic fibrosis assessment and association with pancreatic cancer: comparison with the extracellular volume fraction.
PubMed 文献 · Clin Radiol · 2024-08-12

研究纳入51例(33男,中位年龄69岁;胰腺癌21例,其他疾病30例)行多期增强CT及组织学胰腺纤维化评估者,比较碘洗脱率(IWR)与细胞外容积分数(fECV)评估胰腺纤维化及与胰腺癌的关联。胰腺癌组HPFF和fECV高于对照组,IWR低于对照组;联合IWR与fECV的线性回归模型预测HPFF优于单独使用。

要点

  • 胰腺癌组HPFF 30% vs 对照组12.5%,fECV 40.3% vs 33.0%,均P<0.01。
  • 胰腺癌组IWRPPP-EP 43.3% vs 对照组55.0%,IWRPVP-EP 25.0% vs 33.5%,均P<0.01。
  • HPFF与IWRPPP-EP相关性最强(r=-0.69,P<0.01)。

核心结论

  • IWRPPP-EP、IWRPVP-EP和fECV是无创评估胰腺纤维化的可靠生物标志物,且与胰腺癌风险相关;联合这些变量的线性回归模型提高了预测胰腺纤维化的准确性。

研究设计与样本

  • 纳入51例(33男,中位年龄69岁;胰腺癌21例,其他疾病30例)行多期增强CT及组织学胰腺纤维化评估者,以Azan染色切片评估组织学胰腺纤维化分数(HPFF)为参考标准,测量胰腺实质强化值计算IWR和fECV,采用Spearman's rho和Mann-Whitney U检验,构建线性回归模型预测HPFF并以RMSE和AIC评价性能。

关键影像表现/征象

  • 在估计的横断线上,HPFF与所有CT参数相关,其中与IWRPPP-EP相关性最强(r=-0.69,P<0.01)。
  • 胰腺癌组HPFF为30%,对照组为12.5%,胰腺癌组较高(P<0.01)。
  • 胰腺癌组fECV为40.3%,对照组为33.0%,胰腺癌组较高(P<0.01)。
  • 胰腺癌组IWRPPP-EP为43.3%,对照组为55.0%,胰腺癌组较低(P<0.01)。
  • 胰腺癌组IWRPVP-EP为25.0%,对照组为33.5%,胰腺癌组较低(P<0.01)。

诊断标准与关键数值

  • HPFF与IWRPPP-EP相关性最强(r=-0.69,P<0.01)。
  • 联合IWRPPP-EP+fECV和IWRPVP-EP+fECV的线性回归模型预测HPFF优于单独IWR或fECV模型,RMSE为9.23-9.35,AIC为379.38-380.72。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIMS: To compare the iodine washout rate (IWR) from multiphasic contrast-enhanced computed tomography (CT) with the extracellular volume fraction (fECV) for assessing pancreatic fibrosis and its association with pancreatic cancer.

MATERIALS AND METHODS: The study included 51 individuals (33 men; median age: 69 years; 21 with pancreatic cancer, 30 with other diseases) who underwent multiphasic contrast-enhanced CT and histological evaluation for fibrotic changes in pancreas. The histological pancreatic fibrosis fraction (HPFF) was assessed on Azan-stained sections. Pancreatic parenchymal enhancement values were measured to calculate IWR and fECV. Statistical methods, such as Spearman's rho and Mann-Whitney U-test, were used. Linear regression models using IWR and fECV were constructed to predict HPFF, with the performance expressed as root mean squared error (RMSE) and Akaike information criterion (AIC).

RESULTS: HPFF correlated with all CT parameters at the estimated transection line, strongest for IWRPPP-EP (r=-0.69, P<0.01). HPFF and fECV values were higher in the pancreatic cancer group than in controls (30% vs. 12.5%, P<0.01; 40.3% vs. 33.0%, P<0.01), whereas IWR values were lower (IWRPPP-EP: 43.3% vs. 55.0%, P<0.01; IWRPVP-EP: 25.0% vs. 33.5%, P<0.01). Linear regression models combining IWRPPP-EP + fECV and IWRPVP-EP + fECV were superior for predicting HPFF, with lower RMSE (9.23-9.35) and AIC (379.38-380.72) values than models with IWR or fECV alone.

CONCLUSION: IWRPPP-EP, IWRPVP-EP, and fECV were reliable biomarkers for noninvasively assessing pancreatic fibrosis and were associated with pancreatic cancer risk. Linear regression combining these variables showed enhanced predictive accuracy for pancreatic fibrosis.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Fukui H, Onishi H, Ota T, et al. Pancreatic fibrosis assessment and association with pancreatic cancer: comparison with the extracellular volume fraction. Clin Radiol. 2024. PMID: 39266374. doi:10.1016/j.crad.2024.08.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。